Sign In

Christie VeinViewer technology at 2014 American Society of Anesthesiologists Exhibition

VeinViewer Proven to Improve Patient Safety and Care Pre-operatively

Publication Date: 10/8/2014

MEMPHIS, Tenn. – (October 8, 2014) – Christie Medical Holdings, a global leader in mobile vascular imaging systems, will exhibit its sixth generation VeinViewer® at the American Society of Anesthesiologists’ (ASA) Annual Meeting October 11-13, at booth #1444 in the Ernest N. Morial Convention Center in New Orleans. The annual meeting attracts upwards of 15,000 of the world’s top professionals in anesthesiology, pain medicine and critical care medicine.

Similar to anesthesiology, which is dedicated to pain relief and total patient care before, during and after surgery, VeinViewer is the only vein finder that provides the pre-, during, and post- access information required throughout entire vascular procedures. VeinViewer’s TrueView accuracy helps clinicians find the optimal access point and vessel target while its patented real- time Df² (digital full field) imaging lets medical staff navigate curves in vessels, confirm a patent IV, and react and adjust the technique to help ensure the successful catheter placement. In post-assessment procedures, clinicians can assess the patency of the vessel to help avoid complications.

Erin Shelton, VeinViewer product manager, at Christie Medical Holdings, Inc. said, “In pre-op and the operating room, factors such as the patient’s size and fragility of the vessels, skin tone, and hypertension, among others, can contribute to difficult venous access (DVA). VeinViewer has been clinically proven to improve IV first-stick success by up to 100 percent, reduce pain and improve patient satisfaction.”

VeinViewer uses near-infrared light, DLP® technologies, and exclusive technology such as Active Vascular Imaging Navigation (AVIN™) to create a digital image of patient vasculature in real time.

Overall, VeinViewer can help improve first stick success by up to 100 percent, reduce medically unnecessary PICC lines by over 30 percent, increase patient satisfaction and provide a return on investment to hospitals.

Powerful Results from St. Elizabeth Hospital

Using VeinViewer, a quality improvement study at St. Elizabeth Healthcare in Kentucky revealed a record number of medically unnecessary PICC lines were avoided, resulting in less pain and increased patient satisfaction, equating to more than $200,000 in yearly savings. Read more.

Proven Results

In its “Recommendations for Improving Safety Practices with Short Peripheral Catheters” position paper, the seven-member task force of infusion therapy experts from the Infusion Nurses Society recommended to “incorporate vein visualization technology as a routine strategy for patients with difficult or poor venous access. Visualization technology can improve success rates, decrease unsuccessful insertion attempts, and improve patient satisfaction.” Read more.

To learn more about Christie vein finding devices: VeinViewer Vision2, VeinViewer VisionXTND and VeinViewer Flex, please visit

About Christie Medical Holdings, Inc.

Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit

Follow us on Twitter @christiemed

Christie® is a trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.
DLP® is a registered trademark of Texas Instruments.